| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/24/2001 | CN1281041A Human complement component subunit chain protein isomer and its coding sequence |
| 01/24/2001 | CN1281040A Human actin associated protein compound subunit protein and its coding sequence |
| 01/24/2001 | CN1281039A Human ribosome subunit protein and its coding sequence |
| 01/24/2001 | CN1280985A Recombined human hopatocyte auxin, its preparing process and its clinical application |
| 01/24/2001 | CN1280984A Process for preparing recombined human interleukin-11 by use of hydroxylamine to cut fusion protein |
| 01/24/2001 | CN1280983A Derivant of interleukin-11 and its preparing process |
| 01/24/2001 | CN1061095C Process for preparing glycopeptide antibiotics |
| 01/23/2001 | US6177615 Lepidopteran-toxic polypeptide and polynucleotide compositions and methods for making and using same |
| 01/23/2001 | US6177614 Nucleotide sequences coding polypeptide associated with flowering; for efficient propagation of maize and sorghum hybrids |
| 01/23/2001 | US6177613 Regulatory sequences associated with the transcription of heterologous nucleotide sequences in plants |
| 01/23/2001 | US6177611 Nucleotide sequences associated with activation of transcription in plants; for consistent expression of heterologous nucleotide sequences in plants |
| 01/23/2001 | US6177610 Expression vector coding preferential rodent polypeptide; for use in the treatment of allergic inflammation and asthma |
| 01/23/2001 | US6177556 Nucleotide sequences coding stem cell factor protein; for use in in vitro fertilization therapy |
| 01/23/2001 | US6177554 Nucleic acid transporter systems |
| 01/23/2001 | US6177550 Process for extraction of a growth factor complex |
| 01/23/2001 | US6177549 Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereof |
| 01/23/2001 | US6177547 The specified glycoprotein ligand comprising a fucosylated sialylated glycoprotein containing sialyl lewis x antigen; antibody has binding specific for p-selectin glycoprotein ligand; use modifying inflammatory process, diagnostic assays |
| 01/23/2001 | US6177544 Collagen-based auxiliary agent for ophthalmic surgery |
| 01/23/2001 | US6177543 Homogeneous human lymphokines; for the treatment of tumors; antitumor agents |
| 01/23/2001 | US6177542 Amino acid sequence which activates cell attachment; for utilization as a wound healing agent, tissue maintenance and prevention of tumor propagation; antitumor agents |
| 01/23/2001 | US6177468 Modulation of inflammation related to columnar epithelia |
| 01/23/2001 | US6177410 Therapeutic methods for prostate cancer |
| 01/23/2001 | US6177406 Isolated bone morphogenetic protein-3 (bmp-3) comprising specified amino acid sequence(s); administering to induce formation of chondrocyte and/or cartilage tissue in a patient |
| 01/23/2001 | US6177401 Use of organic compounds for the inhibition of Flk-1 mediated vasculogenesis and angiogenesis |
| 01/23/2001 | US6177275 Plant nitrogen regulatory P-PII genes |
| 01/23/2001 | US6177272 Method for treating vascular proliferative diseases with p27 and fusions thereof |
| 01/23/2001 | US6177261 Promoter activated by regulator and linked to desired protein or peptide and a nucleotide sequence including a promoter and encoding the regulator; regulator is fungal xylanolytic regulator, xylr; obtaining metabolic mutant microorganisms |
| 01/23/2001 | US6177258 Amino acid sequences of protein; for screening enzyme inhibitors for use as parasiticides/insecticides; veterinary medicine |
| 01/23/2001 | US6177257 Immunoassay diagnosis of susceptibility to atherosclerosis by analyzing blood for presence of enzyme using polyclonal or monoclonal antibodies; elevated levels are indicative of susceptibility |
| 01/23/2001 | US6177256 Antigen carbohydrate compounds and their use in immunotherapy |
| 01/23/2001 | US6177254 Nucleolus autoantigenic marker for systemic lupus erthyematosus |
| 01/23/2001 | US6177246 Contacting a tissue or cell with an oligonucleotide of defined nucleotide sequence which hybridizes to nucleic acid encoding abnormally expressed beta-amyloid precursor protein; prophylaxis and treatment of alzheimer's disease |
| 01/23/2001 | US6177244 Oligonucleotide which hybridizes to nucleic acid of defined nucleotide sequence; diagnosis; drug screening; antitumor agents; antimetastasis agents |
| 01/23/2001 | US6177242 Genomic DNA fragments containing regulatory and coding sequences for the β2-subunit of the neuronal nicotinic acetylcholine receptor and transgenic animals made using these fragments or mutated fragments |
| 01/23/2001 | US6177241 Use of peptides to improve specificity of an immunoassay for the detection of cytomegalovirus specific IgM antibody |
| 01/23/2001 | US6177087 Administering a polymer conjugate |
| 01/23/2001 | US6177086 DNA molecule conferring on Mycobacterium tuberculosis resistance against antimicrobial reactive oxygen and nitrogen intermediates |
| 01/23/2001 | US6177085 Immunology |
| 01/23/2001 | US6177084 S. aureusfibrinogen binding protein |
| 01/23/2001 | US6177083 Immunology to gramnegative bacteria |
| 01/23/2001 | US6177082 Cold-adapted equine influenza viruses |
| 01/23/2001 | US6177081 Human and marmoset activating viruses |
| 01/23/2001 | US6177080 Polypeptides encoded by Kaposi sarcoma-associated herpes virus the use thereof in diagnosis and therapy |
| 01/23/2001 | US6177079 Monoclonal antibodies against interleukins |
| 01/23/2001 | US6177078 Binding interleukins |
| 01/23/2001 | US6177075 Insect viruses and their uses in protecting plants |
| 01/23/2001 | US6177060 Nmr or x-ray lymphography images |
| 01/23/2001 | US6177059 Drugs and complexes with lipids |
| 01/23/2001 | CA2296884C Targeted liposomes and methods for liposome-protein coupling |
| 01/23/2001 | CA2221767C A peptide inhibiting elevations of triglyceride levels in blood and an agent for inhibiting elevations of triglyceride levels in blood comprising the peptide as an active component |
| 01/23/2001 | CA2122473C Nuclear matrix protein fluid assay |
| 01/23/2001 | CA2045323C Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide |
| 01/18/2001 | WO2001004356A1 Modulation of egr-1 and egr-2 in heart disease |
| 01/18/2001 | WO2001004344A2 Induction of a th1-like response in vitro |
| 01/18/2001 | WO2001004337A1 Separation and purification of carboxylic acids from fermentation broths |
| 01/18/2001 | WO2001004335A2 Human-bovine chimeric respiratory syncytial virus vaccines |
| 01/18/2001 | WO2001004334A2 Infection with chimaeric adenoviruses of cells negative for the adenovirus serotype 5 coxsacki adenovirus receptor (car) |
| 01/18/2001 | WO2001004329A1 Modified human granulocyte-colony stimulating factor and process for producing same |
| 01/18/2001 | WO2001004328A1 Chlamysin b antibacterial protein, gene encoding it and an expression system for it |
| 01/18/2001 | WO2001004321A1 Production of attenuated respiratory syncytial virus vaccines involving modification of m2 orf2 |
| 01/18/2001 | WO2001004320A1 Attenuated human-bovine chimeric parainfluenza virus (piv) vaccines |
| 01/18/2001 | WO2001004319A1 Mosaic infectious bursal disease virus vaccines |
| 01/18/2001 | WO2001004318A2 Myxoma virus genes for immune modulation |
| 01/18/2001 | WO2001004317A1 Ompa gene for an outer membrane protein of riemerella anatipestifer and methods of use |
| 01/18/2001 | WO2001004316A2 Antigenic meningococcal peptides |
| 01/18/2001 | WO2001004315A2 Ringene compositions and methods for use thereof |
| 01/18/2001 | WO2001004314A2 Nucleic acid molecules and proteins associated with sterol synthesis and metabolism |
| 01/18/2001 | WO2001004313A1 Methods and compositions for preventing the formation of aberrant rna during transcription of a plasmid sequence |
| 01/18/2001 | WO2001004312A1 Proliferation differentiation factor |
| 01/18/2001 | WO2001004311A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/18/2001 | WO2001004310A1 Fc EPSILON RECEPTOR-LUMINESCENCE INDUCING PROTEIN CHIMERIC NUCLEIC ACID MOLECULES, FUSION PROTEINS AND USES THEREOF |
| 01/18/2001 | WO2001004309A1 T-CELL RECEPTOR η ALTERNATE READING FRAME PROTEIN, (TARP) AND USES THEREOF |
| 01/18/2001 | WO2001004308A1 Human lim domain proteins |
| 01/18/2001 | WO2001004307A1 Alpha protein - 27 |
| 01/18/2001 | WO2001004306A1 Expression vectors and methods |
| 01/18/2001 | WO2001004305A2 Human proteins involved in detoxification |
| 01/18/2001 | WO2001004304A1 Human cytokine receptor |
| 01/18/2001 | WO2001004303A1 Compositions corresponding to a calcium transporter and methods of making and using same |
| 01/18/2001 | WO2001004302A1 Atopy gene |
| 01/18/2001 | WO2001004301A1 Fatty acid transporter protein and gene encoding the protein |
| 01/18/2001 | WO2001004300A1 Apoptosis-associated factor |
| 01/18/2001 | WO2001004299A1 AMYLOID β PROTEIN AGGLUTINATION CONTROLLING FACTOR |
| 01/18/2001 | WO2001004298A1 Novel physiologically active substance, process for producing the same and use thereof |
| 01/18/2001 | WO2001004297A2 Human proteins having hydrophobic domains and dnas encoding these proteins |
| 01/18/2001 | WO2001004296A1 Rbp1 polypeptides and uses thereof |
| 01/18/2001 | WO2001004295A1 Orbit and homologues thereof |
| 01/18/2001 | WO2001004294A1 Antimicrobial peptides derived from molluscs |
| 01/18/2001 | WO2001004293A1 Polypeptides and polynucleotides related to a glycine transporter |
| 01/18/2001 | WO2001004292A1 G-protein coupled receptor and dna sequences thereof |
| 01/18/2001 | WO2001004287A1 A method for preparing modified polypeptides |
| 01/18/2001 | WO2001004285A2 Maize msi polynucleotides and methods of use |
| 01/18/2001 | WO2001004283A2 Organic anion transporter genes and proteins |
| 01/18/2001 | WO2001004282A2 Replication-competent anti-cancer vectors |
| 01/18/2001 | WO2001004281A2 Dna coding for beta-tubulin and use thereof |
| 01/18/2001 | WO2001004280A2 Vaccine against lentiviral infections, such as the feline immune deficiency virus of the cat |
| 01/18/2001 | WO2001004272A1 Method to select attenuated paramyxoviridae useful for vaccines and therapeutics |
| 01/18/2001 | WO2001004271A2 Respiratory syncytial viruses expressing immune modulatory molecules |
| 01/18/2001 | WO2001004270A1 Drug target isogenes: polymorphisms in the interleukin 4 receptor alpha gene |
| 01/18/2001 | WO2001004266A1 A lung cancer associated retrovirus, gene delivery vector and methods of use thereof |
| 01/18/2001 | WO2001004264A2 Atherosclerosis-associated genes |